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The adoptive transfer of tumor-antigen specific CD8+ T
lymphocytes has shown highly promising but somewhat
limited benefit in tumor immunotherapy. The poor
objective clinical efficacy observed in early studies has
been overcome partly by integration of patient precondi-
tioning and improved technologies for T cell receptor
gene therapy. Nevertheless, in accordance with results
from peptide vaccine studies, we hypothesize that
further improvement in therapeutic efficacy can be
achieved through addition of tumor-antigen specific
CD4+ T lymphocytes. CD4+ T cells provide pivotal help
for activated cytotoxic T cells, especially by reducing
exhaustion upon chronic antigen stimulation, and by sup-
porting tumor infiltration capacity. In addition, CD4+ T
lymphocytes are critical for the initiation of long lasting
CD8+ T cell memory and can also exert direct antitumor
effector functions, even in the absence of MHC class II
expression. To support a systematic evaluation of poten-
tially beneficial effects of CD4+ T cells in the adoptive T
cell transfer setting, we developed an efficient method for
the activation and isolation of tumor-antigen specific
CD4+ T lymphocytes. Using selected tumor/testis anti-
gens fused to cell internal sorting signals, we were able to
utililze dendritic cells transfected with in vitro transcribed
RNA for the efficient induction of tumor-antigen specific
CD4+ T cells. Via antibody-mediated staining of CD40-
ligand (CD40L) on the surface of specifically reactivated
peripheral blood lymphocytes (PBL), we successfully iso-
lated multiple tumor-antigen specific CD4+ T cell clones
with diverse MHC class II allotype restrictions. Moreover,
a method for the direct identification of CD4+ T cell epi-
tops (DEPI) enabled us to define novel MHC-II restricted
epitopes within the targeted tumor/testis antigens.
Currently, isolated tumor-antigen specific CD4+ T cell
clones are assessed for direct and indirect effector
mechanisms to determine the possible contributions of
CD4+ T lymphocytes in the immunotherapy of cancer.
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